PATENT CLAIM ANALYSIS

Application Number: 16274132
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "181100"]

Abstract:
Benzazepine compounds, conjugates, and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed benzazepine compounds are useful, among other things, in the treating of cancer and modulating TLR8. Additionally, benzazepine compounds incorporated into a conjugate with an antibody construct are described herein.

Claim (Index 33):
The compound of  claim 28 , wherein L 3  is represented by the formula: wherein:\n L 4  represents the C-terminus of the peptide and L 5  is selected from a bond, alkylene and heteroalkylene, wherein L 5  is optionally substituted with one or more groups independently selected from R 32 , and RX is a reactive moiety; and \n R 32  is independently selected at each occurrence from halogen, \u2014OH, \u2014CN, \u2014O\u2014 alkyl, \u2014SH, \u2550O, \u2550S, \u2014NH 2 , \u2014NO 2 ; and C 1-10  alkyl, C 2-10  alkenyl, C 2-10  alkynyl, each of which is optionally substituted with one or more substituents independently selected from halogen, \u2014OH, \u2014CN, \u2014O-alkyl, \u2014SH, \u2550O, \u2550S, \u2014NH 2 , \u2014NO 2 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16274130', '15774262', '15973506', '15509989', '10493279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8183186272837325
- 35 USC 102 Novelty (BERT): 0.5944494785686921
- Combined Prediction Score: 0.7959317124122285
- Mean Citation Score: 477.541558
- Max Citation Score: 547.21844
- Similarity Product: 444.01489933607576

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test